Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | Akt Inhibitor (Pan) |
Profile Name | PTEN K221* |
Drug Class | Akt Inhibitor (Pan) 22 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(22932669) | Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. | Full reference... |
(22487539) | Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. | Full reference... |
(20085938) | The PI3K pathway as drug target in human cancer. | Full reference... |